News

AI model calculates a protein-based stemness index to predict tumor aggressiveness and treatment resistance. Artificial ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...
Brad Arnold, frontman for the Grammy-nominated rock band 3 Doors Down, shared a hopeful health update with fans and expressed ...
Nadunolimab added to carboplatin and gemcitabine (GC) did not impact the safety profile of the chemotherapy and was well tolerated ...
A specially engineered antibody capable of delivering RNA therapies to hard-to-reach, treatment-resistant tumors ...
A specially engineered antibody that can accurately deliver RNA treatments into hard-to-reach and hard-to-treat tumors ...
Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.
Peter Mac researchers have discovered a powerful new drug combination that could offer hope to children and adults with ...
Mantle cell lymphoma treatment offers options if patients relapse after CAR T-cell therapy, from bispecific antibodies, antibody drug conjugates, and other emerging therapies.
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...
Panelists discuss how managing amivantamab-related adverse events such as leg edema requires understanding of underlying ...